DRKS00022441招募中不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Histological confirmed thyroid cancer with focus on anaplastic thyroid cancer and poorly differentiated cancer but also other thyroid cancer entities. The patients must have at least one tumor leasion that can be seen and measured in radiological assessment. They must be over 18 years old and competent.
排除标准
- •<18 years old. Pregnancy.
研究者
相似试验
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200
尚未招募
不适用
Circulating tumor DNA as biomarker for perihilar cholangiocarcinomaPerihilar cholangiocarcinoma/ Perihilair cholangiocarcinoomKlatskin-tumorBiomarkerCirculating tumor DNA /Circulerend tumor DNA (ctDNA)NL-OMON27478AMC20
已完成
不适用
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma: a feasibility studybiliary tract cancerperihilar cholangiocarcinoma10019815NL-OMON43203Academisch Medisch Centrum20
已完成
不适用
ctDNA as a Biomarker for Treatment Response in HNSCCCarcinoma, Squamous Cell of Head and NeckNCT03540563The Netherlands Cancer Institute70
已完成
不适用
Prospective Evaluation of Circulating Tumour DNA (ctDNA) as Molecular Monitoring Tool and Prognostic Biomarker in Resectable Pancreatic AdenocarcinomasC25Malignant neoplasm of pancreasDRKS00010992niversitätsklinikum Freiburg25